1. Advanced glycation end-products produced systemically and by macrophages: A common contributor to inflammation and degenerative diseases
   Kyunghee Byun et al, 2017, Pharmacology & Therapeutics CrossRef
2. HMGB1 Promotes Intraoral Palatal Wound Healing through RAGE-Dependent Mechanisms
   Salunya Tancharoen et al, 2016, International Journal of Molecular Sciences CrossRef
3. Anti-high mobility group box 1 antibody suppresses local inflammatory reaction and facilitates olfactory nerve recovery following injury
   Masayoshi Kobayashi et al, 2018, Journal of Neuroinflammation CrossRef
4. Higenamine promotes M2 macrophage activation and reduces Hmgb1 production through HO-1 induction in a murine model of spinal cord injury
   Zhenyu Zhang et al, 2014, International Immunopharmacology CrossRef
5. High-Mobility Group Box 1 in Spinal Cord Injury and Its Potential Role in Brain Functional Remodeling After Spinal Cord Injury
   Zhiwu Wu et al, 2023, Cellular and Molecular Neurobiology CrossRef
6. Inhibiting HMGB1-RAGE axis prevents pro-inflammatory macrophages/microglia polarization and affords neuroprotection after spinal cord injury
   Hong Fan et al, 2020, Journal of Neuroinflammation CrossRef
7. Experimental justification for the application of different methods for oral mucosal wound closure
   Svetlana V. Tarasenko et al, 2022, Russian Journal of Dentistry CrossRef
8. Designing drugs that encourage spinal cord injury healing
   Barry W Festoff, 2014, Expert Opinion on Drug Discovery CrossRef
9. Therapeutic effects and long-term outcomes of HMGB1-targeted therapy in rats and mice with traumatic spinal cord injury: A systematic review and meta-analysis
   Chen Deng et al, 2022, Frontiers in Neuroscience CrossRef
10. High-Mobility Group Box 1 (HMGB1) Is Elevated Systemically in Persons with Acute or Chronic Traumatic Spinal Cord Injury
    Angelos Papatheodorou et al, 2017, Journal of Neurotrauma CrossRef
11. Overexpression of Receptor for Advanced Glycation End Products and High-Mobility Group Box 1 in Human Dental Pulp Inflammation
    Salunya Tancharoen et al, 2014, Mediators of Inflammation CrossRef
12. Potential of the Angiotensin Receptor Blockers (ARBs) Telmisartan, Irbesartan, and Candesartan for Inhibiting the HMGB1/RAGE Axis in Prevention and Acute Treatment of Stroke
    Kiyoshi Kikuchi et al, 2013, International Journal of Molecular Sciences CrossRef
13. Phosphatidylethanolamine-Binding Protein 1 Ameliorates Ischemia-Induced Inflammation and Neuronal Damage in the Rabbit Spinal Cord
    Woosuk Kim et al, 2019, Cells CrossRef